Table 1.
First author (citation) | Location | Specimen collection period | Specimen type | Specimen size | Typing system | Strain |
---|---|---|---|---|---|---|
Sahi et al. (47) | Seattle, USA, America | 1999–2017 | Whole blood, CSF | 18 | MLST | Eight patients had a 1.1.2 strain; no patients had a 1.3.1 strain; nine patients had a tp0705 type 2 strain. |
Sahi et al. (47) | Seattle, USA, America | 1999–2017 | Whole blood, CSF | 18 | ECDCT | One patient had a 14d/g strain; 16 patients had a tp0548 type f strain. |
Marra et al. (48) | Seattle, USA, America | 1999–2008 | CSF | 84 | ECDCT | 22 patients had a 14d/f strain. |
Dai et al. (50) | Shanghai, China, Asia | 2007–2011 | Lesion swab | 4 | ECDCT | Two patients had a 14d/f strain; two patients had a 19d/c strain. |
Read et al. (51) | Sydney, Australia, Oceania | 2004–2011 | Lesion swab | 2 | ECDCT | Two patients had a 14d/f strain; two of six patients with strain type 14d/f developed neurosyphilis, compared with 0/85 with non-14d/f strains. |
Molepo et al. (46) | Pretoria, South Africa, Africa | 1999–2000 | CSF | 50 | CDC | Seven patients had a 14a strain; four patients had a 3e strain; one patient had a 17e strain; one patient had a 2i strain. |
CSF, cerebrospinal fluid; ECDCT, enhanced CDC-typing; MLST, multi-locus sequence typing.